Praxis Precision Medicines (PRAX) Minority Interest (2019 - 2020)
Praxis Precision Medicines' (PRAX) quarterly Minority Interest came in at $111.9 million in Q3 2020, up 993.87% year-on-year from $10.2 million in Q4 2019, and up 933.36% quarter-over-quarter from $10.8 million in Q2 2020.
Praxis Precision Medicines (PRAX) Minority Interest (2019 - 2020) Analysis & Trends
Praxis Precision Medicines' Minority Interest history runs 2 years deep, the most recent figure standing at $111.9 million for Q3 2020.
- On a quarterly basis, Minority Interest rose 993.87% year-over-year to $111.9 million in Q3 2020; TTM through Sep 2020 was $111.9 million, a 993.87% increase from a year earlier, with the FY2019 full-year figure at $9.9 million, changed N/A from the prior year.
- Minority Interest improved to $111.9 million in Q3 2020 per PRAX's latest filing, from $10.8 million in the prior quarter.
- Across five years, Minority Interest topped out at $111.9 million in Q3 2020 and bottomed at $9.9 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Praxis Precision Medicines | 8.98 Bn | 8.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 111.89 Mn |
| Jun 30, 2020 | 10.83 Mn |
| Dec 31, 2019 | 9.93 Mn |
| Sep 30, 2019 | 10.23 Mn |